Dublin, Aug. 21, 2014 (GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/rx...ar_biology ) has announced the addition of the "Global Molecular Biology Enzymes, Kits, & Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market - Forecast to 2018" report to their offering.
For the purposes of this report the global molecular biology enzymes, kits and reagents market is segmented by application, end users, products, and geographies. Molecular biology enzymes, kits and reagents find applications in a large number of fields of life science research. The application segments included in this report are cloning, epigenetics, PCR (polymerase chain reaction), restriction digestion, sequencing, and other applications. The end-user segments of this market are academic research institutes, hospitals and diagnostics centers, pharmaceutical and biotech companies, and other end users.
The product segments included in this report are enzymes, and kits & reagents. The enzymes segment is divided into the ligases, phosphatases, polymerases, proteases and proteinases, restriction endonucleases, reverse transcriptases, and other enzymes sub-segments. The ligase enzyme sub-segment is further divided into T4 DNA ligase, thermostable DNA ligase, and other ligases. The polymerase enzyme sub-segment is divided into high fidelity DNA polymerase, T4 DNA polymerase, Taq DNA polymerase, and other polymerases, while the restriction endonuclease enzyme sub-segment is divided into BamHI, EcoRI, PstI, and other restriction endonucleases.
The kits and reagents product segment has five sub-segments, namely, cloning and mutagenesis, nucleic acid analysis, PCR sequencing, and other kits and reagents.
The geographic segments included in this report are Asia, Europe, North America and Rest of the World (RoW). Asia is further divided into the regional segments of China, India, Japan, and Rest of Asia. Europe is divided into the regional segments of France, Germany, Italy, Spain, the U.K., and the Rest of Europe. North America includes Canada, and U.S. RoW encompasses Latin America, Middle East and Africa, and the Pacific countries.
The key drivers for this market are the rising R&D expenditure by the pharmaceutical and biotech companies, and increasing public funding for life science research. The World Health Organization estimates that the total aged population may rise from 605 million in 2000 (11% of the global population) to 2 billion by 2050, accounting for 22% of the global population. As this segment of the world population is more susceptible to chronic diseases, research into these ailments will become more significant, driving the growth of the molecular biology enzymes, kits & reagents market.
A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global molecular biology enzymes, kits and reagents market and its sub-segments. Secondary information was used to identify overall revenue, geographic reach, and product portfolios of market players.
Key Topics Covered:
1 Introduction
2 Executive Summary
3 Market Overview
4 Global Molecular Biology Enzymes, Kits, & Reagents Market, By Application
5 Global Molecular Biology Enzymes, Kits, & Reagents Market, By End User
6 Global Molecular Biology Enzymes, Kits, & Reagents Market, By Product
7 Global Molecular Biology Enzymes, Kits, & Reagents Market, By Geography
8 Competitive Landscape
9 Company Profiles
Companies Mentioned:
- Affymetrix
- Agilent Technologies
- Enzymatics
- Illumina
- New England Biolabs
- Qiagen
- Roche
- Sigma-Aldrich Co
- Takara Bio
- Thermo Fisher Scientific
For more information visit http://www.researchandmarkets.com/research/rx...ar_biology
Research and Markets Laura Wood, Senior Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Biotechnology
